STOCKSURGICAL & MEDICAL INSTRUMENTS & APPARATUSUpdated 2026-07-26
Here’s whether Cerus Corp (CERS) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.36% over 10 days); strong 1-year return of +115.4%; 3-month momentum positive (+48.0%). Concerns: RSI 28 — oversold; declining volume on rally — weak conviction (0.76x 30d avg). Currently 15.6% off its 52-week high. Score: +4/7.
CERS is in a confirmed uptrend, trading above both its 50-day ($2.83) and 200-day ($2.20) moving averages. An RSI of 28.4 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of +115.4% compares to +16.5% for SPY (beat the market by 99.0%).
$10,000 invested 1 year ago→ $21,544 today
vs. S&P 500 (SPY) — same period beat market by 99.0%